Home > Cashflow Statement > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Cash Flow from Financing Activities

    Back to Cashflow Statement
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for EMCURE PHARMACEUTICALS
Please provide your vote to see the results

EMCURE PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹-814 Cr₹-164 Cr₹-145 Cr₹-152 Cr₹-189 Cr

What is the latest Cash Flow from Financing Activities ratio of EMCURE PHARMACEUTICALS ?

The latest Cash Flow from Financing Activities ratio of EMCURE PHARMACEUTICALS is ₹-814 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹-814 Cr
Mar2024₹-164 Cr
Mar2023₹-145 Cr
Mar2022₹-152 Cr
Mar2021₹-189 Cr

How is Cash Flow from Financing Activities of EMCURE PHARMACEUTICALS Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹-814 Cr
Negative
Mar2024 ₹-164 Cr
Negative
Mar2023 ₹-145 Cr
Negative
Mar2022 ₹-152 Cr
Negative
Mar2021 ₹-189 Cr -

Compare Cash Flow from Financing Activities of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹31,851.9 Cr 2.4% 1.6% 68.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,848.0 Cr 11.6% 0.7% -0.4% Stock Analytics
DIVIS LABORATORIES ₹172,697.0 Cr 2.3% 8.5% 8.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,859.0 Cr 1.8% -1.8% 30.7% Stock Analytics
DR REDDYS LABORATORIES ₹110,421.0 Cr 0.5% 3.2% 13.3% Stock Analytics
CIPLA ₹105,811.0 Cr 1.2% 5.4% -13.7% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

2.4%

1.6%

68.6%

SENSEX

-1%

2.2%

-3.6%


You may also like the below Video Courses